Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-502,846
Closed -$57.7M 5801
2026
Q1
$57.7M Buy
502,846
+494,025
+5,601% +$43.6M 0.02% 739
2025
Q4
$575K Sell
8,821
-31,520
-78% -$2.51M ﹤0.01% 4856
2025
Q3
$3.31M Sell
40,341
-54,221
-57% -$3.9M ﹤0.01% 3548
2025
Q2
$6.23M Buy
94,562
+43,506
+85% +$2.71M ﹤0.01% 2761
2025
Q1
$3.35M Buy
51,056
+28,686
+128% +$1.94M ﹤0.01% 3274
2024
Q4
$1.72M Buy
+22,370
New +$1.93M ﹤0.01% 3766
2024
Q2
Sell
-61,210
Closed -$4.26M 5811
2024
Q1
$4.26M Buy
61,210
+3,836
+7% +$243K ﹤0.01% 3029
2023
Q4
$3.18M Buy
57,374
+6,009
+12% +$271K ﹤0.01% 3185
2023
Q3
$1.84M Sell
51,365
-190,770
-79% -$6.58M ﹤0.01% 3630
2023
Q2
$7.66M Buy
242,135
+121,337
+100% +$4.64M ﹤0.01% 2283
2023
Q1
$3.72M Buy
120,798
+50,521
+72% +$1.53M ﹤0.01% 2875
2022
Q4
$2.18M Buy
70,277
+49,039
+231% +$1.12M ﹤0.01% 3491
2022
Q3
$399K Sell
21,238
-64,263
-75% -$1.23M ﹤0.01% 5136
2022
Q2
$1.55M Sell
85,501
-5,714
-6% -$73.7K ﹤0.01% 3962
2022
Q1
$1.28M Buy
+91,215
New +$1.53M ﹤0.01% 4300

Other funds holding ACLX

Israel Englander's ACLX Position: Q2 2026 in Review

Israel Englander sold out of Arcellx (ACLX) in Q2 2026, closing a stake of 502,846 shares — an estimated $57.7M sold.

Israel Englander first reported a position in ACLX in Q1 2022 and held it in 15 quarters. The position peaked at $57.7M in Q1 2026. 2 funds tracked by Wall St. Rank hold ACLX as of Q2 2026.

  • Israel Englander reported no remaining Arcellx position as of Q2 2026 after selling out during the quarter.
  • Israel Englander sold 502,846 Arcellx shares in Q2 2026, an estimated $57.7M.
  • Israel Englander first reported a position in Arcellx in Q1 2022 and held it in 15 quarters.
  • Israel Englander's Arcellx position peaked at $57.7M in Q1 2026.
  • 2 funds tracked by Wall St. Rank held Arcellx as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.